Liabilities / Assets
62nd percentile
Tied with the lowest-debt nonprofits in its peer group.
Osteosarcoma Collaborative Inc.
990EZ • Fiscal year 2022 • EIN 82-3882732
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.00x
Liabilities / Revenue
61st percentile
Tied with the lowest-debt nonprofits in its peer group.
Net Margin
84th percentile
Higher net margin than 84% of similar nonprofits.
Top Officer Pay
84th percentile
Higher top officer pay than 84% of similar nonprofits.
Top officer pay equals 0.0% of source-year revenue.
Asset Growth
Score unavailable
No earlier valid filing was available within the previous three public years.
Revenue Growth
Score unavailable
No earlier valid filing was available within the previous three public years.
Balance Sheet
Assets
$176,063
No earlier filing loaded for comparison.
Net Assets
$176,063
No earlier filing loaded for comparison.
Liabilities
$0
No earlier filing loaded for comparison.
Revenue And Expenses
Revenue
$124,324
No earlier filing loaded for comparison.
Expenses
$50,035
No earlier filing loaded for comparison.
Net Income
$74,289
No earlier filing loaded for comparison.
Historical Trend
Jump To
Filing Snapshot
- Filing Period
- Dec 1, 2021 to Nov 30, 2022
- Signed
- Oct 10, 2023
- Return Version
- 2021v4.1
- Gross Receipts
- $124,324
Mission and Program Overview
Mission
The Osteosarcoma Collaborative mission is to educate and advocate for osteosarcoma patients and their families to fund research leading to new therapeutics for those who have this rare and aggressive cancer to advocate surgeons and pathologists to encourage genetic testing for osteosarcoma patients as a change to the standard of care to advocate for better understanding of surgical options including funding the first ever Osteosarcoma Decision Aid and partner with the medical community to change decades old treatment for osteosarcoma
Program Services
| Description | Grants | Expenses |
|---|---|---|
| In 2022 we gave a grant to the MIB Agents for the semi-annual FACTOR conference bringing together over 300 osteosarcoma patients medical professionals advocates and their families As part of that event we sent a board member and a researcher to preview the Osteosarcoma Decision Aid The Aid is the first of its kind surgery decision aid to benefit patients and their families as they are thrown into making life altering decisions shortly after diagnosis This aid has the potential to help thousands of osteosarcoma patients and the coming years and has already benefited many Additionally we were a sponsor for the Pediatric Surgical Oncology Research Group for their annual conference where one of our members spoke to the conference regarding thoracic surgery Osteosarcoma lung mets are the largest reason for lung surgery on young people Finally we updated our website to add more resources on osteosarcoma clinical trials tumor genomics lists of patient support organizations and more | $42,814 | $7,221 |
Compensation and Service Providers
Employees
| Name | Title | Full / Part Time | Base | Other | Total |
|---|---|---|---|---|---|
| Miriam Cohen | President | PT | $0 | - | - |
| Ben Moody | Vice-Chairperson | - | $0 | - | - |
| Christiane Robbins | Chief Scientific Advisor | - | $0 | - | - |
| Lauren Feldman | Treasurer | - | $0 | - | - |
| Theresa Beech | Founding Member | - | $0 | - | - |
Filing and Contact Details
Filer
- Filer Name
- Osteosarcoma Collaborative Inc
- EIN
- 82-3882732
- Phone
- 0000000000
- Address
- 588 CHESTERTOWN ST, GAITHERSBURG, MD 20878
Signing Officer
- Name
- Lauren Feldman
- Title
- Treasurer
- Phone
- 4846209911
- Signed
- 2023-10-10
Supplemental Narrative
Additional Explanations
Schedule O:
“Other Expense: Program Expense $3,877 Travel and Conferences $2,673 Software $323 License and Permits $229 Bank and CC Processing Fees $119 Grants were given to MIB Agents ($25,000) for the 2022 FACTOR Osteosarcoma conference, to University of Indiana ($21,320.50) in the creation of the Osteosarcoma Decision Aid Other Assets - The Osteosarcoma Collaborative has invested in OSTherapies, specifically to be used to make progress in osteosarcoma therapeutics by taking a drug that was used on canines in a successful clinical trial for osteosarcoma, and has received authorization, and is in the final rounds of clinical trials for humans, AOST-2121. Without private funding, this drug trial would not have been possible.”
Raw XML Appendix164 raw XML fields
This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.
| Path | # | Value |
|---|---|---|
| IRS990EZ/ActivitiesNotPreviouslyRptInd | 0 | false |
| IRS990EZ/BenefitsPaidToOrForMembersAmt | 0 | 0 |
| IRS990EZ/BooksInCareOfDetail/PersonNm | 0 | Lauren Feldman |
| IRS990EZ/BooksInCareOfDetail/PhoneNum | 0 | 4846209911 |
| IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt | 0 | 2124 Fox Creek Road |
| IRS990EZ/BooksInCareOfDetail/USAddress/CityNm | 0 | Berwyn |
| IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd | 0 | PA |
| IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd | 0 | 19312 |
| IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt | 0 | 56774 |
| IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt | 0 | 31063 |
| IRS990EZ/ChgMadeToOrgnzngDocNotRptInd | 0 | false |
| IRS990EZ/ContributionsGiftsGrantsEtcAmt | 0 | 124324 |
| IRS990EZ/CostOfGoodsSoldAmt | 0 | 0 |
| IRS990EZ/CostOrOtherBasisExpenseSaleAmt | 0 | 0 |
| IRS990EZ/DirectIndirectPltclExpendAmt | 0 | 0 |
| IRS990EZ/DonorAdvisedFndsInd | 0 | false |
| IRS990EZ/EngagedInExcessBenefitTransInd | 0 | false |
| IRS990EZ/ExcessOrDeficitForYearAmt | 0 | 74289 |
| IRS990EZ/FeesAndOtherPymtToIndCntrctAmt | 0 | 0 |
| IRS990EZ/FiledScheduleAInd | 0 | false |
| IRS990EZ/ForeignFinancialAccountInd | 0 | false |
| IRS990EZ/ForeignOfficeInd | 0 | false |
| IRS990EZ/Form1120PolFiledInd | 0 | false |
| IRS990EZ/Form990TotalAssetsGrp/BOYAmt | 0 | 101774 |
| IRS990EZ/Form990TotalAssetsGrp/EOYAmt | 0 | 176063 |
| IRS990EZ/FundraisingGrossIncomeAmt | 0 | 0 |
| IRS990EZ/GainOrLossFromSaleOfAssetsAmt | 0 | 0 |
| IRS990EZ/GamingGrossIncomeAmt | 0 | 0 |
| IRS990EZ/GrantsAndSimilarAmountsPaidAmt | 0 | 42814 |
| IRS990EZ/GrossProfitLossSlsOfInvntryAmt | 0 | 0 |
| IRS990EZ/GrossReceiptsAmt | 0 | 124324 |
| IRS990EZ/GrossSalesOfInventoryAmt | 0 | 0 |
| IRS990EZ/InitialReturnInd | 0 | X |
| IRS990EZ/InvestmentIncomeAmt | 0 | 0 |
| IRS990EZ/LandAndBuildingsGrp/BOYAmt | 0 | 0 |
| IRS990EZ/LandAndBuildingsGrp/EOYAmt | 0 | 0 |
| IRS990EZ/LobbyingActivitiesInd | 0 | false |
| IRS990EZ/MadeLoansToFromOfficersInd | 0 | false |
| IRS990EZ/MembershipDuesAmt | 0 | 0 |
| IRS990EZ/MethodOfAccountingCashInd | 0 | X |
| IRS990EZ/NetAssetsOrFundBalancesBOYAmt | 0 | 101774 |
| IRS990EZ/NetAssetsOrFundBalancesEOYAmt | 0 | 176063 |
| IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt | 0 | 101774 |
| IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt | 0 | 176063 |
| IRS990EZ/OccupancyRentUtltsAndMaintAmt | 0 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 0 | 7.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 1 | 2.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 2 | 2.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 3 | 3.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 4 | 2.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 0 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 1 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 2 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 3 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 4 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt | 0 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt | 1 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt | 2 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt | 3 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt | 4 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt | 0 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt | 1 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt | 2 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt | 3 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt | 4 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 0 | Miriam Cohen |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 1 | Ben Moody |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 2 | Christiane Robbins |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 3 | Lauren Feldman |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 4 | Theresa Beech |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 0 | President |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 1 | Vice-Chairperson |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 2 | Chief Scientific Advisor |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 3 | Treasurer |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 4 | Founding Member |
| IRS990EZ/OperateHospitalInd | 0 | false |
| IRS990EZ/Organization501c3Ind | 0 | X |
| IRS990EZ/OrganizationDissolvedEtcInd | 0 | false |
| IRS990EZ/OrganizationHadUBIInd | 0 | false |
| IRS990EZ/OtherAssetsTotalDetail/BOYAmt | 0 | 45000 |
| IRS990EZ/OtherAssetsTotalDetail/EOYAmt | 0 | 145000 |
| IRS990EZ/OtherChangesInNetAssetsAmt | 0 | 0 |
| IRS990EZ/OtherExpensesTotalAmt | 0 | 7221 |
| IRS990EZ/OtherRevenueTotalAmt | 0 | 0 |
| IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt | 0 | NONE |
| IRS990EZ/PartVIOfCompOfHghstPdEmplTxt | 0 | NONE |
| IRS990EZ/PoliticalCampaignActyInd | 0 | false |
| IRS990EZ/PrimaryExemptPurposeTxt | 0 | The Osteosarcoma Collaborative mission is to educate and advocate for osteosarcoma patients and their families to fund research leading to new therapeutics for those who have this rare and aggressive cancer to advocate surgeons and pathologists to encourage genetic testing for osteosarcoma patients as a change to the standard of care to advocate for better understanding of surgical options including funding the first ever Osteosarcoma Decision Aid and partner with the medical community to change decades old treatment for osteosarcoma |
| IRS990EZ/PrintingPublicationsPostageAmt | 0 | 0 |
| IRS990EZ/ProgramServiceRevenueAmt | 0 | 0 |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt | 0 | In 2022 we gave a grant to the MIB Agents for the semi-annual FACTOR conference bringing together over 300 osteosarcoma patients medical professionals advocates and their families As part of that event we sent a board member and a researcher to preview the Osteosarcoma Decision Aid The Aid is the first of its kind surgery decision aid to benefit patients and their families as they are thrown into making life altering decisions shortly after diagnosis This aid has the potential to help thousands of osteosarcoma patients and the coming years and has already benefited many Additionally we were a sponsor for the Pediatric Surgical Oncology Research Group for their annual conference where one of our members spoke to the conference regarding thoracic surgery Osteosarcoma lung mets are the largest reason for lung surgery on young people Finally we updated our website to add more resources on osteosarcoma clinical trials tumor genomics lists of patient support organizations and more |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt | 0 | 42814 |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt | 0 | 7221 |
| IRS990EZ/ProhibitedTaxShelterTransInd | 0 | false |
| IRS990EZ/RelatedOrganizationCtrlEntInd | 0 | false |
| IRS990EZ/SalariesOtherCompEmplBnftAmt | 0 | 0 |
| IRS990EZ/SaleOfAssetsGrossAmt | 0 | 0 |
| IRS990EZ/SchoolOperatingInd | 0 | false |
| IRS990EZ/SpecialEventsDirectExpensesAmt | 0 | 0 |
| IRS990EZ/SpecialEventsNetIncomeLossAmt | 0 | 0 |
| IRS990EZ/SubjectToProxyTaxInd | 0 | false |
| IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt | 0 | 0 |
| IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt | 0 | 0 |
| IRS990EZ/TanningServicesProvidedInd | 0 | false |
| IRS990EZ/TotalExpensesAmt | 0 | 50035 |
| IRS990EZ/TotalProgramServiceExpensesAmt | 0 | 7221 |
| IRS990EZ/TotalRevenueAmt | 0 | 124324 |
| IRS990EZ/TransactionWithControlEntInd | 0 | false |
| IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd | 0 | false |
| IRS990EZ/TypeOfOrganizationCorpInd | 0 | X |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt | 0 | 124324 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt | 0 | 33544 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt | 0 | 30647 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt | 0 | 59565 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt | 0 | 248080 |
| IRS990ScheduleA/InvestmentIncomeCYPct | 0 | 0 |
| IRS990ScheduleA/InvestmentIncomePYPct | 0 | 0 |
| IRS990ScheduleA/PubliclySupportedOrg509a2Ind | 0 | X |
| IRS990ScheduleA/PublicSupportCY170Pct | 0 | 0 |
| IRS990ScheduleA/PublicSupportCY509Pct | 0 | 0 |
| IRS990ScheduleA/PublicSupportPY170Pct | 0 | 0 |
| IRS990ScheduleA/PublicSupportPY509Pct | 0 | 0 |
| IRS990ScheduleA/PublicSupportTotal509Amt | 0 | 248080 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt | 0 | 124324 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt | 0 | 33544 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt | 0 | 30647 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt | 0 | 59565 |
| IRS990ScheduleA/Total509Grp/TotalAmt | 0 | 248080 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt | 0 | 124324 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt | 0 | 33544 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt | 0 | 30647 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt | 0 | 59565 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt | 0 | 0 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt | 0 | 248080 |
| IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine1 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorNum | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine1 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine2 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt | 0 | RESTRICTED |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 0 | Other Expense: Program Expense $3,877 Travel and Conferences $2,673 Software $323 License and Permits $229 Bank and CC Processing Fees $119 Grants were given to MIB Agents ($25,000) for the 2022 FACTOR Osteosarcoma conference, to University of Indiana ($21,320.50) in the creation of the Osteosarcoma Decision Aid Other Assets - The Osteosarcoma Collaborative has invested in OSTherapies, specifically to be used to make progress in osteosarcoma therapeutics by taking a drug that was used on canines in a successful clinical trial for osteosarcoma, and has received authorization, and is in the final rounds of clinical trials for humans, AOST-2121. Without private funding, this drug trial would not have been possible. |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 0 | Schedule O: |
| ReturnHeader/BuildTS | 0 | 2023-04-26 12:10:37Z |
| ReturnHeader/BusinessOfficerGrp/PersonNm | 0 | Lauren Feldman |
| ReturnHeader/BusinessOfficerGrp/PersonTitleTxt | 0 | Treasurer |
| ReturnHeader/BusinessOfficerGrp/PhoneNum | 0 | 4846209911 |
| ReturnHeader/BusinessOfficerGrp/SignatureDt | 0 | 2023-10-10 |
| ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt | 0 | OSTEOSARCOMA COLLABORATIVE INC |
| ReturnHeader/Filer/BusinessNameControlTxt | 0 | OSTE |
| ReturnHeader/Filer/EIN | 0 | 823882732 |
| ReturnHeader/Filer/PhoneNum | 0 | 0000000000 |
| ReturnHeader/Filer/USAddress/AddressLine1Txt | 0 | 588 CHESTERTOWN ST |
| ReturnHeader/Filer/USAddress/CityNm | 0 | GAITHERSBURG |
| ReturnHeader/Filer/USAddress/StateAbbreviationCd | 0 | MD |
| ReturnHeader/Filer/USAddress/ZIPCd | 0 | 20878 |
| ReturnHeader/ReturnTs | 0 | 2023-10-10T06:26:50Z |
| ReturnHeader/ReturnTypeCd | 0 | 990EZ |
| ReturnHeader/SigningOfficerGrp/PersonFullName/PersonFirstNm | 0 | Lauren |
| ReturnHeader/SigningOfficerGrp/PersonFullName/PersonLastNm | 0 | Feldman |
| ReturnHeader/TaxPeriodBeginDt | 0 | 2021-12-01 |
| ReturnHeader/TaxPeriodEndDt | 0 | 2022-11-30 |
| ReturnHeader/TaxYr | 0 | 2021 |
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2022 • Form 990EZDetailed filing. Detailed filing data is available for this year.
- Assets
- $176,063
- Liabilities
- $0
- Net assets
- $176,063
- Revenue
- $124,324
- Expenses
- $50,035
- Net income
- $74,289